#Japan #Tokyo #Forensic Science #Wiley #Designer Drugs

Wiley's New Mass Spectra Database for 2026

On March 10, 2026, John Wiley & Sons, Inc. (commonly known as Wiley) unveiled its latest version of the "Mass Spectra of Designer Drugs" database, which is instrumental in the rapid identification of illegal substances in forensic research facilities worldwide. In Japan, Wiley Publishing Japan has commenced sales for this updated resource.

The Evolving Landscape of NPS

The world of new psychoactive substances (NPS) is constantly evolving, introducing numerous novel compounds such as synthetic cannabinoids, metabolites, fentanyl analogs, and their derivatives. As these substances proliferate, forensic and toxicology laboratories require continuously updated and reliable reference data to keep pace with the changing drug market.

Recent Updates in the 2026 Version

The latest edition of the Mass Spectra of Designer Drugs database features significant updates designed to aid forensic, toxicology, and drug-monitoring workflows:

• - Over 700 New Mass Spectra Added
• - 400+ New Compounds Included

- Fentanyl analogs
- Xylazine
- Synthetic opioids such as nitazenes
- Synthetic cannabinoids

• - Comprehensive Coverage of Key NPS Categories

The database now houses a total of 37,075 spectra and includes over 27,900 unique chemical substances.

A Comment from Wiley's Director

Graeme Whitley, Senior Director of Wiley Data Science Solutions, stated:

"The release of the 2026 edition further solidifies Wiley's position as a leading provider of reliable spectral data. We supply research facilities with the high-quality data they need to accurately and efficiently identify emerging designer drugs. These enhancements significantly bolster efforts in forensic science and public health as harmful substances continue to emerge."

Designed for Forensic and Analytical Labs

The Mass Spectra of Designer Drugs database is specifically tailored to meet the needs of forensic and toxicology labs, seamlessly integrated to work with many major mass analysis systems. It is also available as part of Wiley’s analytical software subscription, KnowItAll.

By combining it with KnowItAll, users can leverage advanced analytical functionalities, which include:

• - Drug Classification Models
• - Wiley's Proprietary Technology: MS Adaptive Search

These features allow for swift and precise identification and interpretation of both known and novel compounds. The database serves as an essential resource for laboratories at the forefront of drug detection.

Learn More

For further details, visit Wiley's GC-MS Solutions.

About Wiley Science Solutions

Wiley Science Solutions is a division of Wiley that offers software and scientific data to researchers in analytical sciences and R&D. They provide integrated software and spectral/chemical data to support various analytical fields, including IR, Raman, MS, NMR, and UV-Vis. Their solutions aim to enhance precision and efficiency in research and analysis while reducing errors and improving laboratory productivity. For more info, check out Wiley Science Solutions.

About Wiley

Wiley (NYSE: WLY) is a global enterprise that provides authoritative content and research intelligence to support advancements in scientific research, innovation, and education. With over 200 years at the center of the academic ecosystem, Wiley integrates a longstanding tradition of trustworthy publishing with AI-driven platforms to transform how knowledge is discovered, accessed, and utilized. They assist everyone from researchers and students to Fortune 500 companies in translating scientific discoveries into societal value. In Japan, Wiley Publishing Japan provides products and services.

Transforming knowledge into impact. — Turning knowledge into value.

For more information, please visit Wiley.